Sections
Shows
Glivec
All Stories for Glivec
Why a global fight against cancer is a good idea
Seema Singh •In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries.
From Apple to Novartis: Why some patents deserve to die
Jagannathan •Patents are meant to be given for genuine inventions. Not for minor tweaks. This is why Novartis lost its case with Glivec.
Novartis judgment: Let's make research a priority, rest will follow
Pramod •Our academic and research institutions have to make research a priority and the government has to liberally fund them. The bottomline of the Glivec and recent experiences is simple - we should get our priorities right. The rest will fall in place. <br /><br />
Will not invest in R&D of medicines in India: Novartis chairman
Fp Staff •Drug major Novartis warned that Supreme Court's rejection of its patent plea for cancer drug Glivec will discourage future innovation in India and pointed out that the company has never been granted an original patent for Glivec in the country.
Full text: SC judgement rejecting Novartis patent plea for Glivec
Fp Staff •In a landmark judgement, India's Supreme Court today rejected a patent plea by Swiss drugmaker Novartis AG for cancer drug Glivec, boosting the case for cheaper drugs for life-threatening diseases.
Timeline: How Novartis lost a seven-year long battle over Glivec
Arun •The battle over cancer drug Glivec began in 2006 when the pharmaceutical firm was not granted a patent for the drug.
Novartis patent case: Five facts about the cancer drug Glivec
Fp Staff •Glivec has been a major breakthrough invention of the 20th century for the treatment of cancer. Here are five things you should know about the drug.
Novartis patent case: Section 3(d) of Indian Patent Act explained
Fp Staff •This section states that inventions that are a mere "discovery" of a "new form" of a "known substance" and do not result in increased efficacy of that substance are not patentable.
Boost for cheaper drugs: SC rejects Novartis patent on Glivec
Fp Archives •A decision in the seven-year legal battle is keenly awaited by the two most interested parties- big pharma companies and health aid groups - with both sides saying the outcome will set a precedent with far-reaching consequences for the future availability of the drugs.
Why did PM Modi agree to give away India’s patent sovereignty to Americans?
Pramod •The agreement with the US in the sector will affect India’s sovereignty and the lives of its present and future generations.